KROS

Keros Therapeutics, Inc. Common Stock#22 · 2020BreakoutB

Yearly return

+251%

Peak return

+342%

Max drawdown

-48%

ADR (20 days)

+7.1%

Base

19 days / -47.5%

Prior run

+100%

Breakout volume

2.3x

Pivot

$48.97

Healthcare · Healthcare & Biotech

Continue in the full Atlas

Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare KROS with the current market directly.